CIM
ELV icon

Contravisory Investment Management’s Elevance Health ELV Stock Holding History

Contravisory Investment Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-13,309
Closed -$6.83M – 339
2022
Q4 		$6.83M Buy
13,309
+267
+2% +$136K 1.89% 17
2022
Q3 		$5.92M Buy
13,042
+132
+1% +$63.2K 1.98% 18
2022
Q2 		$6.23M Sell
12,910
-56
-0.4% -$27.7K 2.02% 17
2022
Q1 		$6.37M Buy
12,966
+12,916
+25,832% +$5.9M 1.81% 24
2021
Q4 		$23K Buy
+50
New +$21K 0.01% 243
2019
Q2 		– Sell
-16,965
Closed -$4.87M – 286
2019
Q1 		$4.87M Sell
16,965
-594
-3% -$172K 1.89% 18
2018
Q4 		$4.61M Sell
17,559
-209
-1% -$57.5K 1.99% 15
2018
Q3 		$4.87M Sell
17,768
-655
-4% -$170K 1.75% 23
2018
Q2 		$4.38M Sell
18,423
-171
-0.9% -$39.6K 1.6% 33
2018
Q1 		$4.08M Sell
18,594
-574
-3% -$135K 1.51% 37
2017
Q4 		$4.31M Sell
19,168
-2,088
-10% -$445K 1.56% 35
2017
Q3 		$4.04M Buy
+21,256
New +$4.05M 1.44% 39
2016
Q1 		– Sell
-14
Closed -$2K – 207
2015
Q4 		$2K Buy
+14
New +$1.93K ﹤0.01% 161

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Contravisory Investment Management's ELV Position: Q1 2023 in Review

Contravisory Investment Management sold out of Elevance Health (ELV) in Q1 2023, closing a stake of 13,309 shares — an estimated $6.83M sold.

Contravisory Investment Management first reported a position in ELV in Q4 2015 and held it in 13 quarters. The position peaked at $6.83M in Q4 2022. 1,516 funds tracked by Wall St. Rank hold ELV as of Q1 2023.

  • Contravisory Investment Management reported no remaining Elevance Health position as of Q1 2023 after selling out during the quarter.
  • Contravisory Investment Management sold 13,309 Elevance Health shares in Q1 2023, an estimated $6.83M.
  • Contravisory Investment Management first reported a position in Elevance Health in Q4 2015 and held it in 13 quarters.
  • Contravisory Investment Management's Elevance Health position peaked at $6.83M in Q4 2022.
  • 1,516 funds tracked by Wall St. Rank held Elevance Health as of Q1 2023.

Based on Contravisory Investment Management's 13F filing for Q1 2023, filed 12 Apr 2023.